Charles River expands strategic partnership with SAMDI Tech

By The Science Advisory Board staff writers

January 28, 2022 -- Charles River Laboratories has expanded its strategic partnership with SAMDI Tech. The expanded agreement will provide Charles River's clients seamless access to the label-free, high-throughput screening mass spectrometry (MS) platform in drug discovery.

Under the existing partnership, established in 2018, SAMDI Tech clients have access to Charles River's collection of lead-like compounds for high-throughput screening.

SAMDI's technology combines self-assembled monolayers and matrix-assisted laser desorption/ionization (MALDI) MS and addresses the throughput and sample preparation limitations of traditional MS screening methods. The combination of Charles River's end-to-end portfolio and scientific bench with SAMDI Tech's innovative technology and expertise in assay solutions has the potential to significantly accelerate and augment clients' discovery efforts by measuring biochemical activities and binding events for virtually any target, according to the firms.

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies, and leading academic institutions around the globe accelerate their research and drug development efforts.


Copyright © 2022 scienceboard.net
 

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:



Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Email Preferences



Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.